Interventions to Promote Adherence With Oral Agents

Seminars in Oncology Nursing

Volumn 27, Issue 2, 2011, Pages 133-141

  Schneider, Susan M ^a   Hess, Kimberly ^a   Gosselin, Tracy ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adherence; Cancer; Interventions; Oral chemotherapy; Symptom management

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; HUMAN; NEOPLASM; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; GUIDELINE ADHERENCE; HUMANS; NEOPLASMS;

EID: 79955018187     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2011.02.005     Document Type: Article

References (57)

1. Bedell C.H. A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clin J Oncol Nurs 2003, 7(suppl):5-9.
2. Moore S. Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 2007, 30:112-122. quiz 123-114.
3. Liu G., Franssen E., Fitch M.I., et al. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 1997, 15:110-115.
4. Weingart S.N., Flug J., Brouillard D., et al. Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ 2007, 334:407. [abstr 7590].
5. Barron T.I., Connolly R., Bennett K., et al. Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 2007, 109:832-839.
6. Escalada P., Griffiths P. Do people with cancer comply with oral chemotherapy treatments?. Br J Commun Nurs 2006, 11:532-536.
7. Cramer J.A., Roy A., Burrell A., et al. Medication compliance and persistence: terminology and definitions. Value Health 2008, 11:44-47.
8. Baiardini I., Braido F., Giardini A., et al. Adherence to treatment: assessment of an unmet need in asthma. J Investig Allergol Clin Immunol 2006, 16:218-223.
9. Burra T.A., Chen E., McIntyre R.S., et al. Predictors of self-reported antidepressant adherence. Behav Med 2007, 32:127-134.
10. Chao J., Nau D.P., Aikens J.E. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus. Clin Ther 2007, 29:177-180.
11. Gerbino P.P., Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Syst Pharm 2007, 64:1279-1283.
12. Reynolds N.R. The problem of antiretroviral adherence: a self-regulatory model for intervention. AIDS Care 2003, 15:117-124.
13. DiMatteo M.R., Haskard K.B. Further challenges in adherence research: measurements, methodologies, and mental health care. Med Care 2006, 44:297-299.
14. Nichol M.B., Venturini F., Sung J.C. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999, 33:531-540.
15. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva; 2003. Available at: (Accessed February 18, 2011). http://www.who.int/chp/knowledge/publications/adherence_report/en/.
16. McCollum M., Hansen L.S., Lu L., et al. Gender differences in diabetes mellitus and effects on self-care activity. Gender Med 2005, 2:246-254.
17. Brezinka V., Dusseldorp E., Maes S. Gender differences in psychosocial profile at entry into cardiac rehabilitation. J Cardpulm Rehabil 1998, 18:445-449.
18. Briesacher B.A., Gurwitz J.H., Soumerai S.B. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med 2007, 22:864-871.
19. DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101-2107.
20. Griffin E. Safety considerations and safe handling of oral chemotherapy agents. Clin J Oncol Nurs 2003, 7(suppl):25-29.
21. Harris Interactive Inc. Many U.S. adults disregard doctors' course of treatment. Wall Street Journal Health Poll 2007; Available at: (accessed July 17, 2010). http://www.harrisinteractive.com/NEWS/allnewsbydate.asp?NewsID=1202.
22. Nilsson J.L., Andersson K., Bergkvist A., et al. Refill adherence to repeat prescriptions of cancer drugs to ambulatory patients. Eur J Cancer Care (Engl) 2006, 15:235-237.
23. Elliott R.A., Barber N., Clifford S., et al. The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines. Pharm World Sci 2008, 30:17-23.
24. Decker V., Spoelstra S., Miezo E., et al. A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents. Cancer Nurs 2009, 32:E20-E29.
25. DiMatteo M.R. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004, 23:207-218.
26. Hollywood E., Semple D. Nursing strategies for patients on oral chemotherapy. Oncology (Huntingt) 2001, 15(suppl 2):37-39. discussion 40.
27. Moore K. Out-of-pocket expenditures of outpatients receiving chemotherapy. Oncol Nurs Forum 1998, 25:1615-1622.
28. Wagner L., Lacey M.D. The hidden costs of cancer care: an overview with implications and referral resources for oncology nurses. Clin J Oncol Nurs 2004, 8:279-287.
29. Rector T.S., Venus P.J. Do drug benefits help Medicare beneficiaries afford prescribed drugs?. Health Aff (Millwood) 2004, 23:213-222.
30. Lebovits A.H., Strain J.J., Schleifer S.J., et al. Patient noncompliance with self-administered chemotherapy. Cancer 1990, 65:17-22.
31. Nissen M.J., Beran M.S., Lee M.W., et al. Views of primary care providers on follow-up care of cancer patients. Fam Med 2007, 39:477-482.
32. Back A.L., Arnold R.M., Baile W.F., et al. Approaching difficult communication tasks in oncology. CA Cancer J Clin 2005, 55:164-177.
33. Harrington J., Noble L.M., Newman S.P. Improving patients' communication with doctors: a systematic review of intervention studies. Patient Educ Couns 2004, 52:7-16.
34. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care 2005, 43:517-520.
35. Ansell D., Lacey L., Whitman S., et al. A nurse-delivered intervention to reduce barriers to breast and cervical cancer screening in Chicago inner city clinics. Public Health Rep 1994, 109:104-111.
36. Foley E.C., D'Amico F., Merenstein J.H. Five-year follow-up of a nurse-initiated intervention to improve mammography recommendation. J Am Board Fam Pract 1995, 8:452-456.
37. McCauley K.M., Bixby M.B., Naylor M.D. Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure. Dis Manag 2006, 9:302-310.
38. Vied R.Y., Caron P.A., Rosenthal K.L., et al. Monitoring patient safety with oral chemotherapy: a nurse-managed project. Nurs Spectr (N Engl Ed) 2004, 8:10. [abstr].
39. Bartel S.B. Safe practices and financial considerations in using oral chemotherapeutic agents. Am J Health Syst Pharm 2007, 64(suppl 5):S8-S14.
40. Birner A.M., Bedell M.K., Avery J.T., et al. Program to support safe administration of oral chemotherapy. J Oncol Pract 2006, 2:5-6.
41. ASCO-ONS chemotherapy administration safety standards 2009, American Society of Clinical Oncology, American Society of Clinical Oncology, Alexandria, VA, Available at http://www.asco.org/ASCOv2/Practice+%26+Guidelines/Quality+Care/Quality+Measurement+%26+Improvement/ASCO-ONS+Standards+for+Safe+Chemotherapy+Administration (accessed March 7, 2011).
42. Haynes R.B., Yao X., Degani A., et al. Interventions to enhance medication adherence. Cochrane Database Syst Rev 2005, (4). CD000011.
43. Lee J.Y., Kusek J.W., Greene P.G., et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. Am J Hypertens 1996, 9:719-725.
44. Mayer E.L., Partridge A.H., Harris L.N., et al. Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. Breast Cancer Res Treat 2009, 117:615-623.
45. Ruddy K., Mayer E., Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009, 59:56-66.
46. Kav S., Schulmeister L., Nirenberg A., et al. Development of the MASCC teaching tool for patients receiving oral agents for cancer. support. Care Cancer 2010, 18:583-590.
47. DeCardenas R., Helfrich J.S. Oral therapies and safety issues for oncology practices patient support is key to delivering safe oral chemotherapy. Oncology Issues March/April 2010, 40-42.
48. Ringe J.D., van der Geest S.A.P., Moller G. Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence. Drugs Aging 2006, 23:569-578.
49. Miloh T., Annunziato R., Arnon R., et al. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics 2009, 124:e844-e850.
50. Openshaw T. Profile of primary investigator: Dr. Tom Openshaw. 2010; Profile. Available at: (accessed July 13, 2010). http://www.mainegenetics.org/index.php?option=com_content%26view=article%26id=22%26Ite.
51. Wolpin S. Improving medication adherence for patients with low functional health literacy 2009, University of Washington; NIH-US Department of Health & Human Services, Seattle, WA.
52. Haynes R.B., Ackloo E., Sahota N., et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008, (2). CD000011.
53. Partridge A.H., Avorn J., Wang P.S., et al. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002, 94:652-661.
54. Simons S., Ringsdorf S., Braun M., et al. Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support Care Cancer 2010, [ePub ahead of press].
55. American Nurse Today. Practice Matters. American Nurse Today 2007;2:36.
56. Winkeljohn D. Adherence to oral cancer therapies: nursing interventions. Clin J Oncol Nurs 2010, 14:461-466.
57. Hede K. Increase in oral cancer drugs raises thorny issues for oncology practices. J Natl Cancer Inst 2009, 101:1534-1536.